Pre-eclampsia physical examination

Jump to navigation Jump to search

Pre-eclampsia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pre-eclampsia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pre-eclampsia physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pre-eclampsia physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pre-eclampsia physical examination

CDC on Pre-eclampsia physical examination

Pre-eclampsia physical examination in the news

Blogs on Pre-eclampsia physical examination

Directions to Hospitals Treating Pre-eclampsia

Risk calculators and risk factors for Pre-eclampsia physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Ogheneochuko Ajari, MB.BS, MS [3]

Overview

Patients with preeclampsia usually appear edematous .Physical examination may be remarkable for:Hyperreflexia, vision loss or deficit, altered sensorium , confusion, Rale in lungs field, Limbs edema. Posterior reversible encephalopathy syndrome should be considered in the setting of preeclampsia in patients with vision loss or deficit, seizure, headache, and altered sensorium or confusion.

Physical examination

References

  1. Ikeda, Masahiro; Ito, Shuichi; Hataya, Hiroshi; Honda, Masataka; Anbo, Kazutoshi (2001). "Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome". American Journal of Kidney Diseases. 37 (4): e30.1–e30.3. doi:10.1016/S0272-6386(01)90016-2. ISSN 0272-6386.